CLINICAL_TRIALS
trial_result
· 2012-08-24
Clinical Trial Update: Celebrex (Celecoxib) Treatment of Laryngeal Papilloma [Phase 2]
Summary
A Phase 2 trial evaluating Celecoxib (Celebrex) for treating laryngeal papillomatosis was terminated, with results posted on 2012-08-24.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston University | Conditions: Laryngeal Papilloma | Phase 2 | Status: TERMINATED | Results posted: 2012-08-24